TY - JOUR
T1 - Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults
AU - Alexander, Gene E.
AU - Bergfield, Kaitlin L.
AU - Chen, Kewei
AU - Reiman, Eric M.
AU - Hanson, Krista D.
AU - Lin, Lan
AU - Bandy, Daniel
AU - Caselli, Richard J.
AU - Moeller, James R.
N1 - Funding Information:
We thank Tricia Merkeley and Melaney Aschenbrenner for their technical assistance and help with data collection. This work was supported by the Alzheimer's Association ( IIRG-02-3784 ), the National Institute of Mental Health ( MH57899 ), the National Institute on Aging ( AG025526 , AG19610 , and AG031581 ), the state of Arizona and Arizona Department of Health Services, Arizona Advanced Research Institute for Biomedical Imaging, and the Evelyn F. McKnight Brain Institute.
PY - 2012/12
Y1 - 2012/12
N2 - The apolipoprotein E (APOE) ε4 allele increases the risk for late-onset Alzheimer's disease (AD) and age-related cognitive decline. We investigated whether ε4 carriers show reductions in gray matter volume compared with ε4 non-carriers decades before the potential onset of AD dementia or healthy cognitive aging. Fourteen cognitively normal ε4 carriers, aged 26 to 45 years, were compared with 10 age-matched, ε4 non-carriers using T1-weighted volumetric magnetic resonance imaging (MRI) scans. All had reported first- or second-degree family histories of dementia. Group differences in gray matter were tested using voxel-based morphometry (VBM) and a multivariate model of regional covariance, the Scaled Subprofile Model (SSM). A combination of the first two SSM MRI gray matter patterns distinguished the APOE ε4 carriers from non-carriers. This combined pattern showed gray matter reductions in bilateral dorsolateral and medial frontal, anterior cingulate, parietal, and lateral temporal cortices with covarying relative increases in cerebellum, occipital, fusiform, and hippocampal regions. With these gray matter differences occurring decades before the potential onset of dementia or cognitive aging, the results suggest longstanding, gene-associated differences in brain morphology that may lead to preferential vulnerability for the later effects of late-onset AD or healthy brain aging.
AB - The apolipoprotein E (APOE) ε4 allele increases the risk for late-onset Alzheimer's disease (AD) and age-related cognitive decline. We investigated whether ε4 carriers show reductions in gray matter volume compared with ε4 non-carriers decades before the potential onset of AD dementia or healthy cognitive aging. Fourteen cognitively normal ε4 carriers, aged 26 to 45 years, were compared with 10 age-matched, ε4 non-carriers using T1-weighted volumetric magnetic resonance imaging (MRI) scans. All had reported first- or second-degree family histories of dementia. Group differences in gray matter were tested using voxel-based morphometry (VBM) and a multivariate model of regional covariance, the Scaled Subprofile Model (SSM). A combination of the first two SSM MRI gray matter patterns distinguished the APOE ε4 carriers from non-carriers. This combined pattern showed gray matter reductions in bilateral dorsolateral and medial frontal, anterior cingulate, parietal, and lateral temporal cortices with covarying relative increases in cerebellum, occipital, fusiform, and hippocampal regions. With these gray matter differences occurring decades before the potential onset of dementia or cognitive aging, the results suggest longstanding, gene-associated differences in brain morphology that may lead to preferential vulnerability for the later effects of late-onset AD or healthy brain aging.
KW - Apolipoprotein E
KW - Gray matter volume
KW - Late-onset Alzheimer's disease
KW - Magnetic resonance imaging
KW - Multivariate analysis
KW - Voxel-based morphometry
UR - http://www.scopus.com/inward/record.url?scp=84866759212&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84866759212&partnerID=8YFLogxK
U2 - 10.1016/j.neurobiolaging.2012.01.014
DO - 10.1016/j.neurobiolaging.2012.01.014
M3 - Article
C2 - 22405043
AN - SCOPUS:84866759212
SN - 0197-4580
VL - 33
SP - 2723
EP - 2732
JO - Neurobiology of Aging
JF - Neurobiology of Aging
IS - 12
ER -